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Abstract
Background: A recent publication described a supervised classification method for microarray
data: Between Group Analysis (BGA). This method which is based on performing multivariate
ordination of groups proved to be very efficient for both classification of samples into pre-defined
groups and disease class prediction of new unknown samples. Classification and prediction with
BGA are classically performed using the whole set of genes and no variable selection is required.
We hypothesize that an optimized selection of highly discriminating genes might improve the
prediction power of BGA.
Results: We propose an optimized between-group classification (OBC) which uses a jackknife-
based gene selection procedure. OBC emphasizes classification accuracy rather than feature
selection. OBC is a backward optimization procedure that maximizes the percentage of between
group inertia by removing the least influential genes one by one from the analysis. This selects a
subset of highly discriminative genes which optimize disease class prediction. We apply OBC to
four datasets and compared it to other classification methods.
Conclusion: OBC considerably improved the classification and predictive accuracy of BGA, when
assessed using independent data sets and leave-one-out cross-validation.
Availability: The R code is freely available [see Additional file 1] as well as supplementary
information [see Additional file 2].
Background
Gene expression microarrays enable the simultaneous
measurement of the expression levels of thousands of
genes. Supervised classification of gene expression data
aims to identify combinations of genes which give the
best discrimination of groups of samples specified in
advance. For such methods, which are classically used in
disease class prediction, the identification of a subset of
discriminating genes can be critical [1,2]. Indeed, a large
proportion of genes are generally non-informative in
terms of disease class prediction. A gain in classification
and prediction performance can be expected when
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predictors are built upon a subset of highly discriminating
genes [3,4].
Several algorithms capable of selecting a subset of predic-
tive genes were recently proposed [5]. These methods
include a genetic algorithm [6], maximum difference sub-
set algorithm (MDSS) [7], support vector machines [8,9],
a shrunken centroids technique [2,10] and several which
use of discriminant functions [11].
However, two issues remain: 1) different subsets of genes
may provide comparable optimal discriminations [1]; 2)
it is generally difficult to determine the optimal number
of genes for discrimination [12,13]. This number may
vary according to the number of individuals in the train-
ing set, the number of groups to discriminate and the
method used for classification and prediction. Dolédec
and Chessel [14] developed a supervised classification
approach, Between Group Analysis (BGA), which was
recently applied to microarray data [15]. The authors spec-
ified several key features of BGA that make it a method of
choice for sample classification and class prediction. In
BGA, all genes participate in the discrimination. Conse-
quently, no gene selection step is required. On the other
hand, BGA calculates group means and is therefore sensi-
tive to outliers. Our objective was to improve the robust-
ness of BGA by optimizing the number of discriminating
genes supporting the analysis.
In this study, we propose a new jackknife-based algorithm
– optimized between-group classification (OBC) – that
produces a selection of the most robust discriminating
genes in order to improve the accuracy of disease class pre-
diction. The criterion optimized in OBC is the percentage
of between group inertia (% BG inertia). OBC is applied
to BGA but it could also be associated with other super-
vised methods. We tested the efficiency of OBC on four
datasets using independent test sets and leave-one-out
cross-validation (LOOCV). We compared our approach to
different classification methods.
Results
Outline of the OBC algorithm
OBC can be described in three steps (Figure 1). These
steps are detailed below. Each dataset used in this study
was systematically split into a training set and a test set.
OBC was applied exclusively to the training set.
Pre-selection of discriminating genes – step 1
In the first step, pre-selection of a few hundred most dis-
criminating genes is made. This is to reduce the number of
calculations and computational resources in step 2
(below). This initial set of discriminating genes is
obtained from a BGA of the whole training set (including
all genes). Genes with the highest scores on BGA discrim-
inating axes, those located at extremities of BGA axes, are
collected. For datasets where samples are grouped into 2
categories (binary categorization), we selected an equal
amount of genes at each end of the single discriminating
BGA axis. For datasets with more than two categories, we
chose genes projected at the periphery of each pair of dis-
criminating axes using a "peeling" function (successive
2D convex hulls).
Jackknife optimization – step 2
This second step of the algorithm is cpu and time consum-
ing. Due to computational limitations, the number of pre-
selected genes should be in the order of a few hundreds
(the optimization of 150 genes and 24 samples required
1 h 50 min on a Pentium 4 2.66 GHz computer). Strate-
gies to reduce calculation time are discussed below.
Classification accuracy by LOOCV
The performance of the subsets of predictive genes was
assessed using LOOCV. To perform LOOCV, a sample is
removed from the dataset and a BGA is performed on the
remaining samples. The excluded sample is projected on
to the BGA and classified. This is iteratively performed
until all samples have been subjected to cross-validation.
The percentage of samples correctly classified by cross-val-
idation is calculated. This parameter measures the predic-
tion accuracy of the subset of genes.
Optimization criterion
The objective of OBC is to improve the discrimination
efficiency of BGA, by excluding genes which contribute
least to the % BG inertia of samples. OBC uses a jackknife
iteration to maximize the between group inertia while
minimizing the within group inertia. The inertia decom-
position can be described as follow.
Let us suppose N the number of samples (xi is the ith sam-
ple and wi its weight), dist(xi, xj) the squared Euclidean
distance between two samples xi and xj, K the number of
groups (Gk is the kth group) and Nk the number of individ-
uals in the kth group. Potentially distances other than
Euclidean could be used. In a preliminary analysis we
found that the Euclidean distance performs similarly to
Manhattan distance. Therefore, given its relative ease of
implementation, we use Euclidean distance throughout
our analyses. By using a weighted pair-group average cal-
culation, the total inertia can be decomposed into within
group inertia (Eq. 1) and between group inertia (Eq. 2).
The algorithm aims to maximize the percentage of
between group inertia, i.e. the ratio of the between group
inertia to the total inertia (Eq. 3).
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% BG inertia = BG inertia/(WG inertia + BG inertia)   (3)
Measurement of the contribution of each individual gene using 
jackknifing
We assessed sequentially the influence of each gene in the
remaining gene subset using a jackknife procedure. In
jackknife analysis, we remove a gene, perform a BGA on
the dataset and calculate the % BG inertia. If we remove a
Overall description of OBC Figure 1
Overall description of OBC. Three steps are required to perform OBC optimization. In the first pre-selection step, n most 
discriminating genes are selected by performing a BGA on the training set with the whole set of genes. In the second step, a 
jackknife optimization is performed on the initial subset of genes and the least influential genes in terms of % BG inertia are 
removed successively. This second step is iteratively computed, decrementing the genes down to 5. Finally in the third step, 
the optimal subset of genes is identified (subset with the best classification accuracy and the best stability).
■ Step 1: Pre-selection of discriminating genes
→ Run a BGA on the initial training set with the whole
set of genes
→ Select the n most discriminating genes
■ Step 2: Jackknife's optimization
→ Measure the classification accuracy of the subset of
genes using LOOCV*
→ Assess the contribution of each gene in terms of % BG
inertia by jackknifing
→ Measure the variance of % BG inertia
→ Remove the least influential gene**
»S TEP 2 IS COMPUTED ITERATIVELY, DECREMENTING THE GENES DOWN TO 5«
■ Step 3: Identification of the optimal subset of genes
→ Determine the number of genes of the optimized subset
of genes based on accuracy (% of correct classification
by LOOCV) and stability (variance of % BG inertia)
* The statistical significance of the optimized BGA is assessed with a
Monte-Carlo permutation test
** The prediction power of genes remaining in the model can be tested as
the model progresses by measuring the % of samples in the independent test
set correctly classified
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gene which positively contributes to the between group
discrimination, the % BG inertia decreases and vice versa.
By comparing the % BG inertia before and after removing
a given gene, one can assess the influence of this gene. In
addition, we assess the stability of the % BG inertia during
jackknife (described later).
Jackknife approaches have been previously used in the
context of gene selection [7,16]. As an example, Lyons-
Weiler et al. (2003) [7] used jackknifing to reduce the false
positive rate of a gene set. In the present study, we used
jackknifing to progressively eliminate the least discrimi-
native genes from a subset of genes.
Backward optimization
At each step of the algorithm, the gene that contributes
least to the % BG inertia is removed from the dataset.
Another jackknife procedure is then performed with the
remaining genes. This backward optimization algorithm
reduces the number of genes from a large subset (typically
a few hundreds of genes) to a minimal subset (fixed to
minimum of 5).
Stability and robustness of the optimization – variance of % BG 
inertia and Monte-Carlo permutation test
The variance of % BG inertia was used as a measure of the
stability of the optimization. By jackknifing a subset of n
genes, we obtain n values of % BG inertia. The range of
variation of these values is the variance of % BG inertia.
During backward optimization the number of genes
included in the classifier gets smaller, and the effect of the
jackknife perturbation measured by the variance of % BG
inertia tends to increase. If this variance is high, the
robustness and the stability of the prediction model is
low. Consequently, low variance of % BG inertia is
preferable.
Throughout the optimization, the statistical significance
of BGA is evaluated with a Monte-Carlo permutation test.
Identification of the optimal subset of genes for disease 
class prediction – step 3
The optimal subset of genes are identified with the aid of
the summary diagram which summarizes the results of
the algorithm. The optimal subset of genes should have
both high LOOCV prediction accuracy and stability (i.e.
minimal variance of % BG inertia). If optimization of
these two parameters resulted in a range of near optimal
solutions, we chose subsets with fewer genes and higher %
BG inertia. Importantly, although we calculate prediction
accuracy of the independent test set, these results were
never taken into account in OBC, as this would result in
over-training.
Application of OBC to sarcoidosis data
Between group analysis
Standard BGA was applied to the whole sarcoidosis train-
ing data set. The biplot representation shows that BGA
separated the three phenotypes with no overlap (Figure 2,
panel A). The first axis separated the healthy controls from
the sarcoidosis patients. The second axis separates the two
stages of sarcoidosis. The efficiency of classification of
new samples was measured using LOOCV. Seventy-five
percent of the 24 samples were classified correctly. How-
ever, we observed discrepancies in classification accuracy
between the three phenotypes. All healthy controls, 6 out
of 7 stage I, but none of the stage II/III sarcoidosis patients
were correctly re-classified. When we tried to predict the
classification of a blind test of 8 follow-up patients, using
this BGA of the whole set of genes, only 50% of these test
samples were correctly classified. Four out of five patients,
which recovered 6 months after they were diagnosed with
a stage I sarcoidosis, were classified in the healthy group.
All of the patients still suffering from active sarcoidosis
stage II/III (n = 3) were incorrectly classified.
Optimized between group classification
We selected the 105 most discriminating genes in this ini-
tial BGA, using the above mentioned peeling procedure
(Figure 2, panel C). OBC was applied on this subset of
genes. The least influential genes in terms of % BG inertia
were removed one by one.
Figure 2 (panel B) shows the evolution of classification
parameters; % BG inertia, % correct classification in
LOOCV, and variance of % BG inertia. During the optimi-
zation process, the % BG inertia increased when the
number of genes decreased until it reached an optimum,
then it decreased when the number of genes fell below
this optimum threshold. The percentage of correct classi-
fication in LOOCV was stable in a range of 20–70 genes.
When the number of genes further decreased, it started to
oscillate. The variance of % BG inertia was very low for
subsets of more than 58 genes. This parameter increased
considerably for subsets fewer than 57 genes. Finally, the
dotted line represents the evolution of percentage of test
sets correctly classified (this parameter was not considered
during optimization).
The subset of genes with the best cross-validation effi-
ciency and least variable % BG inertia was judged to be the
optimal subset. Therefore, this was a subset of 58 genes
(Figure 2, panel C). The accuracy of LOOCV obtained
using this optimized subset of genes was clearly improved
since 96% of samples were correctly classified (100, 80
and 100% respectively in sarcoidosis stage I, stage II/III
and healthy controls). Figure 2 (panel D) shows the pro-
jection of 8 follow-up samples predicted by this subset of
classifiers. These predictions were also improved since 2/BMC Bioinformatics 2005, 6:239 http://www.biomedcentral.com/1471-2105/6/239
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Optimized between-group classification applied to sarcoidosis data Figure 2
Optimized between-group classification applied to sarcoidosis data. In panel A, 24 individuals (solid circles) in the 
training set (H: healthy controls, SI: sarcoidosis stage I, SII: sarcoidosis stage II/III) and 8 individuals (empty circles) in the test 
set (283, 286, 287, 289 and 290 as H; 282, 284 and 285 as SII) are classified by a standard BGA using the whole set of genes. 
Panel B shows the different parameters of OBC as a function of the number of genes used in the analysis: the percentage of 
between group inertia (solid line), the percentage of good cross-validation (dashed line) and the variance of between group 
inertia (dot-dashed line). For indication, the percentage of test samples correctly predicted is represented by a dotted line. This 
parameter was not used in optimization of the training model. The vertical line shows the optimal number of genes. In panel C, 
the 105 most discriminating genes (initial subset) are located at the periphery of the biplot (black crosses) and the 58 optimal 
genes are highlighted (circled crosses). In panel D, 8 test-samples are classified using a BGA based on the 58 optimal genes.
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3 of sarcoidosis stage II/III were correctly associated to
their group, whereas 4/5 of patients in remission from a
stage I sarcoidosis were classified as healthy. Patient 283,
who was mis-classified, clinically recovered from a sar-
coidosis stage I. It is possible that signals of gene activity
specific to stage I sarcoidosis be still detectable in this
patient.
Application of OBC to tumour data
Between group analysis
BGA was applied to the whole tumour training set [20].
BGA clearly separated the 4 different types of tumours
with no overlap (Figure 3, panel A). Based upon the com-
plete set of 2308 genes, the LOOCV showed that 93% of
the 63 samples from the training set were correctly cross-
validated and 19/20 of the test sets were correctly pre-
dicted. The most discriminating genes associated with the
different groups were identified at the periphery of the
BGA biplot (Figure 3, panel C).
Optimized between-group classification
From the initial BGA, the 245 most discriminating genes
were selected. We applied the optimization algorithm to
this initial subset. We used the optimization diagram to
determine the optimal subset of genes. As shown in dia-
gram Figure 3, panel B, there was a range of near optimal
solutions (high % of correct cross-validation and low var-
iance of % BG inertia). We decided to choose an optimal
subset of 90 genes for which the accuracy, the stability and
the % BG inertia were high.
The results of BGA using the 90 optimal genes are plotted
in Figure 3 (panel C). The accuracy of LOOCV, of BGA on
the 63 training samples using the 90 optimal genes,
increased to 100%. All 20/20 test sets were correctly clas-
sified (Figure 3 panel D).
Stability of OBC and test of significance
The stability of OBC was controlled by monitoring the
evolution of variance of % BG inertia. This parameter was
of great importance as it monitored whether the classifica-
tion was overly influenced by a few genes.
The Monte-Carlo permutation test was constantly signifi-
cant for the different datasets (estimated p-value = 0.001).
This result suggests that our method is robust.
Sensitivity and specificity
We built confusion matrices from the results obtained
from LOOCV and classification of independent test sets.
Then, we calculated the sensitivity and specificity of BGA
and OBC for each disease category. Sensitivity measures
the proportion of individuals correctly classified for a
given disease class (true positives). Specificity measures
the proportion of individuals that do not belong to the
class and which are not classified in this class (true nega-
tives). The sensitivities and specificities of OBC vs. stand-
ard BGA are summarized in Tables 1 and 2.
Figure 4 shows the sensitivity as a function of 1 – specifi-
city of BGA with and without optimization (black dots
and white dots, respectively), when applied to the sar-
coidosis and tumour datasets (panels A and B, respec-
tively). The results of LOOCV and classification of
independent test sets are shown in the left and right plots
respectively.
We observed an improvement in prediction sensitivity
and specificity of both the sarcoidosis (Figure 4A) and
tumour datasets (Figure 4B) when OBC was applied in
LOOCV and independent test sample cross validation.
Comparison with other algorithms
We compared OBC with three other recently described
gene selection methods: the GA/KNN algorithm [6], max-
imal margin linear programming (MAMA) [17] and near-
est shrunken centroid [10]. Results (Table 3) show that
OBC outperforms these approaches in terms of accuracy
of LOOCV and classification of independent test sets.
Comparisons between BGA and other supervised classifi-
cation methods [15] report that BGA outperforms or per-
forms with similar effectiveness.
OBC applied to datasets with binary categorization
Colon cancer dataset
We assessed the prediction accuracy of OBC when applied
to the colon cancer data set, which contains two categories
of tumor samples. We applied OBC optimization to the
100 most discriminating genes. Results of LOOCV, show
an increase of accuracy from 85% for standard BGA to
94% for OBC (based on 20 optimized genes). We investi-
gated the sensitivity and specificity of OBC classification
prediction when applied to independent test data. We
built 26 pairs of training sets/test sets by randomly split-
ting the complete data set of 62 samples into training sets
of 40 samples and test sets of 22 samples. OBC produced
an improvement in both the sensitivity (83% to 87%) and
specificity (87% to 91%) of prediction.
Leukemia dataset
We compared the prediction accuracy of BGA and OBC
using LOOCV of the whole dataset. The percentage of
samples correctly predicted in LOOCV was 90% for BGA
and 99% for OBC (based on 40 optimized genes). Simi-
larly to the colon cancer data analysis, we built 24 pairs of
training sets/test sets by randomly splitting the whole
dataset into 50 training and 22 test samples. Application
of OBC to the leukemia dataset improved the sensitivity
and specificity of test set classification. When OBC was
applied, the sensitivity of classification was improved forBMC Bioinformatics 2005, 6:239 http://www.biomedcentral.com/1471-2105/6/239
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Optimized between-group classification applied to tumour data Figure 3
Optimized between-group classification applied to tumour data. In panel A, 63 samples (solid circles) of the training 
set (BL: Burkitt's lymphoma, EWS: Ewing's sarcoma, NB: neuroblastoma, RMS: rhabdomyo sarcoma) and 25 samples (empty 
circles) of the test set (7, 15 and 18 as BL-NHL; 2, 6, 12, 19, 20 and 21 as EWS; 1, 8, 14, 16, 23 and 25 as NB; 4, 10, 17, 22 and 
24 as RMS; 3, 5, 9, 11 and 13 as control samples that do not belong to one of the 4 groups) are classified by the standard BGA 
based on the whole set of genes. Panel B shows the different parameters of OBC as a function of the number of genes used in 
the analysis: the percentage of between group inertia (solid line), the percentage of good cross-validation (dashed line) and the 
variance of between group inertia (dot-dashed line). For indication, the percentage of test samples correctly predicted is repre-
sented by a dotted line. This parameter was not used in optimization of the training model. The vertical line shows the optimal 
number of genes. In panel C, the 245 most discriminating genes are represented with small crosses and the 90 optimal genes 
are highlighted (circled crosses). In panel D, the 25 test-samples are classified using a BGA based on the 90 optimal genes.
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both ALL (97% to 99%) and AML (91% to 92%). The spe-
cificity of prediction of both ALL and AML samples was
also improved (respectively, 91% to 92% and 97% to
99%).
Discussion
Selection of genes that optimize disease class prediction is
a significant and difficult challenge in microarray data
analysis. Most discriminative functions require more cases
than variables which is not realistic in the context of
microarray experiments. A further challenge is the consid-
erable amount of noise in microarray data. BGA can be
applied to complete datasets without prior gene selection
and performs comparably or outperforms several other
approaches [15]. We showed that an optimized gene
selection considerably improves the predictive power of
BGA. Our jackknife-based algorithm tests the robustness
of BGA discriminating genes and progressively excludes
weaker discriminators. As a consequence, it optimizes the
performance of BGA and reduces the number of discrimi-
nating genes.
The OBC algorithm presented here might be time con-
suming depending on the size of the initial subset of
genes. Increasing the number of genes in the initial dataset
ensures that more potentially discriminative genes are
present in the analysis. However, the time required for the
optimization process increases significantly. We assessed
the percentage of gain in % BG inertia obtained by
increasing the number of genes in the initial subset. This
number depends on the dataset and in particular the
number of groups to discriminate. The optimal number of
genes of OBC starting genes is around 100 for the sar-
coidosis data and 150–200 in the tumour data (Figure 5).
In OBC, the choice of the initial subset of genes from
which the algorithm starts remains critical and alternative
procedures might be used. For example, the genetic algo-
rithm proposed by Li et al. (2001) [6] could be associated
to OBC and might provide some improvements in
performance.
Different options could be considered to speed up the
algorithm. We considered removing more than one least
influential gene at a time in the jackknife optimization.
The execution time would decrease proportionally to the
number of genes removed at each step. For example, if we
removed 10 % least influential genes from the subset of
genes at each step, we could greatly increase the speed of
execution of the algorithm. With this, it would be possible
to include a few thousands of genes in the initial subset of
genes. The decision on how many genes to remove per
jackknife cycle is a trade off between testing more combi-
nations of genes (and therefore testing more efficiently
Table 1: Sensitivity and specificity of OBC compared with standard BGA in sarcoidosis dataset.
LOOCV Test set
HS IS I IHS IS I I
OBC Sensitivity 1 1 0.8 0.8 - 0.67
Specificity 0.92 1 1 1 0.5 1
BGA Sensitivity 1 0.86 0 0.8 - 0
Specificity 0.83 0.82 0.95 1 0.75 1
Table 2: Sensitivity and specificity of OBC compared with standard BGA in tumour dataset.
LOOCV Test set
E W SN BR M S B LE W SN BR M S B L
OBC Sensitivity 1 1 1 1 1 1 1 1
Specificity 1 1 1 1 1 1 1 1
BGA Sensitivity 0.87 1 0.9 1 1 0.83 1 1
Specificity 0.975 0.98 0.93 1 1 1 0.93 1BMC Bioinformatics 2005, 6:239 http://www.biomedcentral.com/1471-2105/6/239
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Analysis of sensitivity and specificity Figure 4
Analysis of sensitivity and specificity. The sensitivity and specificity of OBC (solid circles) were compared to standard 
BGA (empty circles). The prediction accuracy of OBC when applied to the sarcoidosis dataset was assessed using (A) LOOCV 
(left panel) and classification of the independent dataset (right panel). OBC was also applied to the tumour dataset and tested 
using (B) LOOCV (left panel) and classification of the independent dataset (right panel). Arrows show the improvement of sen-
sitivity and specificity obtained with OBC compared to the standard BGA.
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gene-gene interactions) and including more genes in the
analysis. On the other hand, the numerous tasks per-
formed during the optimization could be split into several
jobs, which could be potentially computed in parallel by
a cluster of processors/computers. Finally another solu-
tion would be to rewrite the computationally demanding
parts of the algorithm in a more efficient computer lan-
guage like C.
We decided to choose a backward optimization procedure
as this seemed to be more adapted for taking possible
gene-gene interactions into account. The prediction
power of a single gene might be negligible in itself while
it might be preponderant when associated with one or a
few other genes. Removing a gene that jointly participates
with other genes to the group discrimination will have an
impact, which is measurable by a backward approach,
whereas no evidence might be found by using a forward
optimization.
Our results show that an improvement in discriminative
and predictive power of BGA can be achieved by reducing
the number of predictors in the analysis to a small subset
of highly discriminative genes. These genes contribute to
improve the % BG inertia. In this study, two criteria were
used to define the optimal subset of genes: a positive cri-
terion, the percentage of correct classification by LOOCV
and a negative criterion the variance of % BG inertia.
When searching for the subset of genes where both criteria
were optimized, we generally found a range of near opti-
mal solutions. In the sarcoidosis dataset, the size of the
optimal subset of genes was around 60, whereas in the
tumour dataset, subsets including around 90 genes were
found to be optimal. By using a method that associates a
genetic algorithm with the k-nearest neighbors technique
(GA/KNN) on a lymphoma dataset, Li et al. (2001) [6]
concluded that using only a few discriminating genes may
not be reliable, whereas using too many genes will add
noise to the classification. They suggested 50–200 genes
would give an optimal result which is in agreement with
our study.
Conclusion
We propose OBC, a novel jackknife-based backward opti-
mization algorithm, which improves both the classifica-
tion and predictive power of BGA. Our algorithm tended
to outperform alternative classification techniques. In the
Table 3: Comparison of the accuracy of OBC with different classification methods.
Dataset Method % correct LOOCV % correct prediction of 
independent test samples
Sarcoidosis OBC 96% 75%
BGA 75 50
GA/KNN 92 62.5
MAMA 67 62.5
Shrunken centroids 791 62.51
Tumour OBC 100 100
BGA 92.6 95
GA/KNN 100 95
MAMA 98 76
Shrunken centroids 1002 902
1Threshold of 2.801
2Threshold of 2.459
Number of genes included in the initial subset Figure 5
Number of genes included in the initial subset. This 
plot shows the maximum % BG inertia reached by the opti-
mization procedure as a function of the number of genes 
present in the initial subset of genes (top curve: tumour data; 
bottom curve: sarcoidosis data). The dashed lines delimit the 
optimal size of the initial subset of genes for both datasets 
(above which the gain in % BG inertia is lower).
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future, OBC could be used as a decision making-tool for
disease class prediction based on gene expression data in
various clinical situation. Future developments will
include the application of the algorithm to different
supervised methods.
Methods
Data sets
Sarcoidosis data
The gene expression study was carried out on 12 healthy
controls (H), 7 sarcoidosis stage I patients (SI) and 5 sar-
coidosis stage II/III patients (SII). This dataset was pub-
lished previously and details can be found in [18]. These
24 samples correspond to the sarcoidosis training set. In
addition, 6 months later, 8 follow-up chips were done for
some of the sarcoidosis patients. Among these patients, 3
still had active sarcoidosis stage II/III and 5 were recovered
from sarcoidosis stage I. These 8 supplementary samples
correspond to the sarcoidosis test set. The expression level
of 12626 probe sets was measured with Affymetrix' Gene-
Chip® (HG-U95Av2). The complete dataset and the raw
files have been deposited in NCBIs Gene Expression
Omnibus (GEO) [19], and are accessible through GEO
Series accession number GSE1907.
Tumour data
This dataset was published by Khan et al. (2001) [20]. The
authors measured the expression of 6567 genes in four
types of small round blue cell tumours (NB: neuroblast-
oma; RMS: rhabdomyo sarcoma; BL: Burkitt's lymphoma;
EWS: Ewing's sarcoma). A filtered dataset containing the
expression level of 2308 genes is publicly accessible [21].
The whole dataset contained 88 samples split into a train-
ing set (63 samples) and a test set (25 samples).
Colon cancer data
This colon cancer dataset was studied by Alon et al.
(1999) [22]. It contained 62 samples obtained from 40
tumor samples and 22 control samples. Gene expression
profiles were analyzed using Affymetrix' microarrays con-
taining more than 6500 genes. This dataset was randomly
split into training sets and test sets (40 and 22 samples,
respectively). This dataset is available as a Bioconductor
data package [23].
Leukemia data
The leukemia dataset [24] contained 72 samples from
patients having two types of acute leukemia. Among the
72 patients, 47 had acute lymphoblastic leukemia (ALL)
and 25 had acute myeloid leukemia (AML). Samples were
obtained from bone marrow or peripheral blood. Gene
expression profiling was analyzed with Affymetrix' micro-
arrays containing 7159 probe sets. This dataset was ran-
domly split into training sets and test sets (50 and 22
samples, respectively). The dataset is available as a Bio-
conductor data package [25].
Software and statistical analysis
The OBC algorithm was written in R (version 1.9.1), an
open-source statistical software [26]. The algorithm is
freely available [see Additional file 1] and further infor-
mation can be find as well [see Additional file 2]. Some
specific R packages were used in this study: the Biocon-
ductor packages for microarray analysis [27]; ADE4 [28]
and MADE4 [29] for multivariate analysis. The sarcoidosis
dataset was normalized using the vsn algorithm [30].
Between group analysis
BGA is a particular extension of conventional ordination
methods such as principal component analysis (PCA) or
correspondence analysis (COA) where groups of samples
are specified in advance [14]. The association of COA with
BGA is particularly powerful, as COA has been shown to
have several advantages over PCA in analysis of gene
expression data [31,32]. In order to simplify the notations
in the paper, the acronym BGA refers to the between-
group correspondence analysis.
The between group analysis of the statistical triplet (X, Q,
D) – where X is a data table of n rows (samples) and p col-
umns (variables), Q is a p × p diagonal matrix containing
the variable weights and D is a n × n diagonal matrix
containing the sample weights – given the class indicator
f, is the analysis of the triplet (G, Q, Dw) where G is the
table of the means of X per group and Dw is the diagonal
matrix of group weights [28]. Let us consider K  the
number of specified groups, a typical BGA yields K - 1 dis-
criminating axes that ordinate the groups of sample by
maximizing the between group variance (see [15] for
mathematical details). Linear discriminant analysis is a
related method which aims to maximize the percentage of
variance explained by the grouping but which has differ-
ent constraints and which cannot be applied to tables
where the number of variables exceeds the number of
samples [33].
Genes and samples ordinated by BGA can be projected on
discriminating axes and visualized simultaneously on a
biplot. The most discriminating genes are projected at the
extremity of each axis whereas less informative genes are
projected near the origin of each axis.
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